These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28842605)

  • 41. Equilibrative nucleoside transporter 2 is expressed in human umbilical vein endothelium, but is not involved in the inhibition of adenosine transport induced by hyperglycaemia.
    Aguayo C; Casado J; González M; Pearson JD; Martín RS; Casanello P; Pastor-Anglada M; Sobrevia L
    Placenta; 2005; 26(8-9):641-53. PubMed ID: 16085043
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structure-Activity Relationship Studies of 4-((4-(2-fluorophenyl)piperazin-1-yl)methyl)-6-imino-N-(naphthalen-2-yl)-1,3,5-triazin-2-amine (FPMINT) Analogues as Inhibitors of Human Equilibrative Nucleoside Transporters.
    Li R; Mak WW; Li J; Zheng C; Shiu PH; Seto SW; Lee SM; Leung GP
    Front Pharmacol; 2022; 13():837555. PubMed ID: 35264969
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cloning of the human equilibrative, nitrobenzylmercaptopurine riboside (NBMPR)-insensitive nucleoside transporter ei by functional expression in a transport-deficient cell line.
    Crawford CR; Patel DH; Naeve C; Belt JA
    J Biol Chem; 1998 Feb; 273(9):5288-93. PubMed ID: 9478986
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential Inhibition of Equilibrative Nucleoside Transporter 1 (ENT1) Activity by Tyrosine Kinase Inhibitors.
    Jouan E; Moreau A; Bruyere A; Alim K; Denizot C; Parmentier Y; Fardel O
    Eur J Drug Metab Pharmacokinet; 2021 Sep; 46(5):625-635. PubMed ID: 34275128
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gestational diabetes reduces adenosine transport in human placental microvascular endothelium, an effect reversed by insulin.
    Salomón C; Westermeier F; Puebla C; Arroyo P; Guzmán-Gutiérrez E; Pardo F; Leiva A; Casanello P; Sobrevia L
    PLoS One; 2012; 7(7):e40578. PubMed ID: 22808198
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Purine uptake and release in rat C6 glioma cells: nucleoside transport and purine metabolism under ATP-depleting conditions.
    Sinclair CJ; LaRivière CG; Young JD; Cass CE; Baldwin SA; Parkinson FE
    J Neurochem; 2000 Oct; 75(4):1528-38. PubMed ID: 10987833
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transport characteristics of HL-1 cells: a new model for the study of adenosine physiology in cardiomyocytes.
    Chaudary N; Shuralyova I; Liron T; Sweeney G; Coe IR
    Biochem Cell Biol; 2002; 80(5):655-65. PubMed ID: 12440705
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reduced ability to release adenosine by diabetic rat cardiac fibroblasts due to altered expression of nucleoside transporters.
    Podgorska M; Kocbuch K; Grden M; Szutowicz A; Pawelczyk T
    J Physiol; 2006 Oct; 576(Pt 1):179-89. PubMed ID: 16873415
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Deletion of equilibrative nucleoside transporter 2 disturbs energy metabolism and exacerbates disease progression in an experimental model of Huntington's disease.
    Chen CY; Chou FY; Chang YG; Ho CJ; Wu KC; Hsu CL; Chern Y; Lin CJ
    Neurobiol Dis; 2023 Feb; 177():106004. PubMed ID: 36669543
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anticancer nucleobase analogues 6-mercaptopurine and 6-thioguanine are novel substrates for equilibrative nucleoside transporter 2.
    Nagai K; Nagasawa K; Kihara Y; Okuda H; Fujimoto S
    Int J Pharm; 2007 Mar; 333(1-2):56-61. PubMed ID: 17088032
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Basolateral uptake of nucleosides by Sertoli cells is mediated primarily by equilibrative nucleoside transporter 1.
    Klein DM; Evans KK; Hardwick RN; Dantzler WH; Wright SH; Cherrington NJ
    J Pharmacol Exp Ther; 2013 Jul; 346(1):121-9. PubMed ID: 23639800
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transepithelial fluxes of adenosine and 2'-deoxyadenosine across human renal proximal tubule cells: roles of nucleoside transporters hENT1, hENT2, and hCNT3.
    Elwi AN; Damaraju VL; Kuzma ML; Mowles DA; Baldwin SA; Young JD; Sawyer MB; Cass CE
    Am J Physiol Renal Physiol; 2009 Jun; 296(6):F1439-51. PubMed ID: 19297449
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Localization and Expression of Nucleoside Transporters ENT1 and ENT2 in Polar Cells of Intestinal Epithelium.
    Senyavina NV; Gerasimenko TN; Fomicheva KA; Tonevitskaya SA; Kaprin AD
    Bull Exp Biol Med; 2016 Apr; 160(6):771-4. PubMed ID: 27160886
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nucleoside transporter expression and adenosine uptake in the rat cochlea.
    Khan AF; Thorne PR; Muñoz DJ; Wang CJ; Housley GD; Vlajkovic SM
    Neuroreport; 2007 Feb; 18(3):235-9. PubMed ID: 17314663
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adenosine A(2B) receptor-mediated VEGF induction promotes diabetic glomerulopathy.
    Cárdenas A; Toledo C; Oyarzún C; Sepúlveda A; Quezada C; Guillén-Gómez E; Díaz-Encarnación MM; Pastor-Anglada M; San Martín R
    Lab Invest; 2013 Jan; 93(1):135-44. PubMed ID: 23069939
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Saturable Hepatic Extraction of Gemcitabine Involves Biphasic Uptake Mediated by Nucleoside Transporters Equilibrative Nucleoside Transporter 1 and 2.
    Shimada T; Nakanishi T; Tajima H; Yamazaki M; Yokono R; Takabayashi M; Shimada T; Sawamoto K; Miyamoto K; Kitagawa H; Ohta T; Tamai I; Sai Y
    J Pharm Sci; 2015 Sep; 104(9):3162-9. PubMed ID: 26037416
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Blockade of equilibrative nucleoside transporter 1/2 protects against Pseudomonas aeruginosa-induced acute lung injury and NLRP3 inflammasome activation.
    Chambers ED; White A; Vang A; Wang Z; Ayala A; Weng T; Blackburn M; Choudhary G; Rounds S; Lu Q
    FASEB J; 2020 Jan; 34(1):1516-1531. PubMed ID: 31914698
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Amelioration of lipopolysaccharide-induced memory impairment in equilibrative nucleoside transporter-2 knockout mice is accompanied by the changes in glutamatergic pathways.
    Wu KC; Lee CY; Chern Y; Lin CJ
    Brain Behav Immun; 2021 Aug; 96():187-199. PubMed ID: 34058310
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular cloning and functional characterization of inhibitor-sensitive (mENT1) and inhibitor-resistant (mENT2) equilibrative nucleoside transporters from mouse brain.
    Kiss A; Farah K; Kim J; Garriock RJ; Drysdale TA; Hammond JR
    Biochem J; 2000 Dec; 352 Pt 2(Pt 2):363-72. PubMed ID: 11085929
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Contribution of equilibrative nucleoside transporter(s) to intestinal basolateral and apical transports of anticancer trifluridine.
    Takahashi K; Yoshisue K; Chiba M; Nakanishi T; Tamai I
    Biopharm Drug Dispos; 2018 Jan; 39(1):38-46. PubMed ID: 29055025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.